Tandyukisin demonstrated significant inhibitory activity against cancer cells expressing high levels of EGFR, while exhibiting negligible inhibitory effects on both low EGFR-expressing cancer cells and normal human breast cells. The gene discussed is EGFR; the disease is cancer.